Starpharma Holdings Limited (OTCMKTS:SPHRY) Short Interest Down 65.4% in December

Starpharma Holdings Limited (OTCMKTS:SPHRY) was the target of a large drop in short interest during the month of December. As of December 15th, there was short interest totalling 900 shares, a drop of 65.4% from the November 30th total of 2,600 shares. Based on an average trading volume of 700 shares, the days-to-cover ratio is currently 1.3 days.

Starpharma Price Performance

SPHRY traded up $0.04 on Thursday, hitting $0.64. The company had a trading volume of 100 shares, compared to its average volume of 3,125. The company has a quick ratio of 4.58, a current ratio of 4.94 and a debt-to-equity ratio of 0.07. The company’s fifty day moving average price is $0.67 and its 200 day moving average price is $0.64. Starpharma has a 1 year low of $0.52 and a 1 year high of $1.25.

Starpharma Company Profile

Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. The company offers VivaGel BV, a non-antibiotic vaginal gel for the treatment of bacterial vaginosis and prevention of recurrent BV; VIRALEZE, an antiviral nasal spray; and VivaGel condom, an antiviral condom.